Related Experiment Video
Updated: Jul 26, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
A prospective study of Chlamydia pneumoniae infection and risk of MS in two US cohorts
K L Munger1, G N DeLorenze, L I Levin
1Department of Nutrition, Harvard School of Public Health, Boston, MA 02115, USA.
Background:
Chlamydia pneumoniae (Cpn) has been proposed as a possible etiologic agent in multiple sclerosis (MS). However, previous studies were cross-sectional and could not assess whether Cpn infection preceded the onset of MS.
Methods:
The authors conducted a prospective nested case-control study among 3 million US Army personnel and 121,466 members of the Kaiser Permanente Medical Care Program (KPMCP) cohort. Serum samples collected prior to onset of MS symptoms were available for 83 MS cases in the Army and 46 in the KPMCP cohort. Two controls were matched to each case on age, sex, and date of blood collection. Microimmunofluorescence was used to measure serum immunoglobulin M (IgM) and immunoglobulin G (IgG) antibody titers to Cpn; IgG titers > or 1:16 were considered positive for past Cpn infection.
Results:
Seropositivity for Cpn was not significantly associated with risk of MS in either cohort (Army: OR = 1.0; 95% CI 0.6, 1.8; KPMCP: OR = 1.5; 95% CI 0.7, 3.1) or in the pooled analysis (OR = 1.2; 95% CI 0.8, 1.9). Serum levels of anti-Cpn IgG antibody were also not associated with an increased risk of MS in the Army (OR for a fourfold difference in antibody titers = 0.9; 95% CI 0.7, 1.2) or in the pooled analysis (OR = 1.2; 95% CI 0.9, 1.4), but a significant increase in risk was seen in the KPMCP cohort (OR = 1.7; 95% CI 1.2, 2.5). The difference between these results in the Army and the KPMCP cohort was significant (p = 0.01).
Conclusions:
Neither Cpn seropositivity nor serum anti-Cpn IgG antibody titers predicted risk of developing MS. However, due to the heterogeneity of results between cohorts, we cannot exclude the possibility that infection with Cpn may modify the risk of MS.
Insights
Chlamydia pneumoniae infection does not appear to predict multiple sclerosis (MS) risk, despite prior hypotheses. Further research is needed to understand any potential link between Cpn and MS development.
Area of Science:
- Infectious Disease Epidemiology
- Neurology
- Immunology
Background:
- Chlamydia pneumoniae (Cpn) has been investigated as a potential cause of multiple sclerosis (MS).
- Previous studies were limited by their cross-sectional design, preventing assessment of infection timing relative to MS onset.
Purpose of the Study:
- To prospectively investigate the association between Chlamydia pneumoniae infection and the subsequent risk of developing multiple sclerosis.
- To determine if Cpn infection precedes the onset of MS symptoms.
Main Methods:
- A prospective nested case-control study was conducted using serum samples from US Army personnel and Kaiser Permanente Medical Care Program (KPMCP) members.
- Serum samples collected before MS symptom onset were analyzed for Cpn immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies using microimmunofluorescence.
- Cases of MS were matched with controls based on age, sex, and blood collection date.
Main Results:
- No significant association was found between Cpn seropositivity and the risk of developing MS in either the Army or KPMCP cohorts, or in pooled analysis.
- While most analyses showed no increased MS risk with higher anti-Cpn IgG titers, the KPMCP cohort showed a significant increase (OR = 1.7; 95% CI 1.2, 2.5).
- A significant heterogeneity in results between the Army and KPMCP cohorts was observed (p = 0.01).
Conclusions:
- Cpn seropositivity and serum anti-Cpn IgG antibody titers did not predict the risk of developing MS in this prospective study.
- The observed heterogeneity between cohorts suggests that the role of Cpn infection in MS risk cannot be definitively excluded.
- Further investigation is warranted to clarify the potential modifying role of Cpn infection in MS pathogenesis.
More Related Videos
04:55A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice
Published on: May 11, 2022
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Bacterial Phylum Chlamydiae
Atypical Pneumonia
Multiple Sclerosis l: Introduction